Mioinositol (1 g), D-chiro-inositol (25 mg), Melatonin (1.9 mg), CoQ10 (100 mg) Vitamin D3 (25 µg), Quatrefolic®(400 µg), L. crispatus (1x109), L. gasseri (2x109), Iron (28 mg), Zinc (15 mg) Yodo (0.2 mg) Vitamin B6
1. Ovocyte bonding
2. Control hyperhomocysteinemia risk factor (microtrombos)
3. Control risk factor endometrial dysbiosis
4. Pregnancy preparation
? Improves the quality of oocyte and embryo in patients with SOP (via Mioinositol+D-Chiro-inositol)
? Reduces DNA alterations and increases pregnancy rate (CoQ10)
? Reduces oxidative damage inside the follicle, increases LH and progesterone receptors (via melatonin)
? Quatrefolic® (folic), vitamin B6 and Vitamin B12, reduce homocysteine levels, which has a positive impact on subfertile patients.
? The implantation rate drops dramatically in patients with less abundance of lactobaciles at endometrial level.
? The predominance of L. crispatus in the vaginal flora of patients under intrauterine insemination was the only factor strongly associated with the success of the technique.
_
APTO Intolerant to lactose APTO celiac.
Unique with the inositoles a physiological ratio (40:1) ? The only one with the ratio D-chiro-inositol- mioinositol in physiological balance (40:1) and according to the current evidence (Revision Cochrane, 20191) on the role of the inositols in the regulation of the menstrual cycle.
Project co-financed by the European Social Fund Asturias 2014/2020, within the Consolidation operation Ticket Empresarial 2016